PIEDMONT INVESTMENT ADVISORS INC - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 388 filers reported holding NEKTAR THERAPEUTICS in Q3 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
PIEDMONT INVESTMENT ADVISORS INC ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q1 2020$282,000
-15.6%
15,819
+2.2%
0.01%
-8.3%
Q4 2019$334,000
-29.7%
15,485
+9.5%
0.01%
-36.8%
Q1 2019$475,000
+4.4%
14,146
+2.1%
0.02%
-13.6%
Q4 2018$455,000
-42.7%
13,857
+6.3%
0.02%
-33.3%
Q3 2018$794,000
+792.1%
13,033
+612.6%
0.03%
+725.0%
Q2 2018$89,000
-95.4%
1,829
-94.3%
0.00%
-89.7%
Q4 2017$1,933,000
+136.6%
32,367
-5.0%
0.04%
+129.4%
Q3 2017$817,000
+24.5%
34,053
+1.5%
0.02%
+13.3%
Q2 2017$656,000
+203.7%
33,545
+264.6%
0.02%
+275.0%
Q1 2017$216,0009,2010.00%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q3 2018
NameSharesValueWeighting ↓
Strong Tower Advisory Services 404,972$6,913,0004.02%
GREAT POINT PARTNERS LLC 504,691$9,064,0002.11%
Camber Capital Management LP 3,750,000$67,350,0002.07%
ACT CAPITAL MANAGEMENT, LLC 161,500$2,901,0001.50%
Rhenman & Partners Asset Management AB 950,000$17,062,0001.20%
MAVERICK CAPITAL LTD 5,838,426$104,858,0001.06%
Birchview Capital, LP 72,000$1,293,0000.88%
Bellevue Group AG 4,594,656$82,519,0000.84%
CM Management, LLC 50,000$898,0000.67%
Duquesne Family Office 1,000,000$17,960,0000.58%
View complete list of NEKTAR THERAPEUTICS shareholders